{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:42:03Z","timestamp":1771645323572,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.clindermatol.2011.08.006","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T05:37:06Z","timestamp":1319089026000},"page":"622-632","source":"Crossref","is-referenced-by-count":20,"title":["Iatrogenic skin injury in hospitalized patients"],"prefix":"10.1016","volume":"29","author":[{"given":"Carol E.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Kroshinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2011.08.006_bb0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199102073240605","article-title":"The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II","volume":"324","author":"Leape","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJM199102073240604","article-title":"Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I","volume":"324","author":"Brennan","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/intqhc\/12.5.371","article-title":"A comparison of iatrogenic injury studies in Australia and the USA. I: context, methods, casemix, population, patient and hospital characteristics","volume":"5","author":"Thomas","year":"2000","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking","volume":"36","author":"Walsh","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0025","first-page":"556","article-title":"Clinical features of drug-induced hypersensitivity syndrome in 38 patients","volume":"20","author":"Um","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0030","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archdermatol.2010.361","article-title":"Failure to recognize and manage patients with DRESS","volume":"146","author":"England Owen","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4168\/aair.2010.2.2.123","article-title":"Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and Stevens-Johnson syndrome","volume":"2","author":"Jeung","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1346-8138.2010.01176.x","article-title":"New aspects of drug-induced hypersensitivity syndrome","volume":"38","author":"Tohyama","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D3676552R9","article-title":"Drug-induced linear IgA bullous dermatosis","volume":"12","author":"Navi","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0060","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaad.2009.03.026","article-title":"Drug-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon","volume":"62","author":"McDonald","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0065","unstructured":"Schwendiman MN, Turiansky GW. What is your diagnosis? Linear IgA dermatosis. Cutis 2010;86:117, 125-8."},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0070","first-page":"29","article-title":"Linear IgA bullous disease in a patient with Crohn's disease","volume":"19","author":"Torres","year":"2010","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)61454-8","article-title":"A successful challenge in a patient with vancomycin-induced linear IgA dermatosis","volume":"93","author":"Joshi","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-0960.2001.00515.x","article-title":"Drug-induced linear IgA bullous disease following antibiotics","volume":"42","author":"Wiadrowski","year":"2001","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000279318","article-title":"Linear IgA disease: successful application of immunoadsorption and review of the literature","volume":"220","author":"Kasperkiewicz","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0090","series-title":"Dermatology","first-page":"291","author":"Bolognia","year":"2003"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000148255","article-title":"Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis","volume":"217","author":"Yun","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0105","first-page":"51","article-title":"Review of intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"2","author":"Momin","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in US burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","article-title":"A 10-year experience with toxic epidermal necrolysis","volume":"21","author":"Schulz","year":"2000","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajo.2009.08.040","article-title":"Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids","volume":"149","author":"Shammas","year":"2010","journal-title":"Am J Ophthamology"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1529-8019.2011.01396.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options","volume":"24","author":"Worswick","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0130","first-page":"29","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options","volume":"50","author":"Teo","year":"2009","journal-title":"Singapore Med J"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","article-title":"Treatment of toxic epidermal necrolysis with highdose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases","volume":"139","author":"Prins","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatment on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","volume":"48","author":"Arevalo","year":"2000","journal-title":"J Trauma"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","article-title":"Antitumor necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis","volume":"146","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0155","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J All Clin Immunol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/00015550510037062","article-title":"Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab","volume":"85","author":"Al-Shouli","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0165","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1468-3083.2006.02026.x","article-title":"Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases","volume":"21","author":"Meiss","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2340\/00015555-0462","article-title":"Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis","volume":"88","author":"Wojtkiewicz","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0175","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","article-title":"Risk factors for acute generalized exanthematous pustulosis (AGEP)\u2014results of a multinational case-control study (EuroSCAR)","volume":"157","author":"Sidoroff","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0180","first-page":"410","article-title":"Profile of acute generalized exanthematous pustulosis in Israel during 2002-2005:results of the RegiSCAR Study","volume":"10","author":"Davidovici","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-4632.2010.04313.x","article-title":"Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore","volume":"49","author":"Lee","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1398-9995.2008.01890.x","article-title":"Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children","volume":"64","author":"Mailhol","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0536.2010.01851.x","article-title":"The relevance of chlorhexidine contact allergy","volume":"64","author":"Liippo","year":"2011","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0200","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-0536.2008.01559.x","article-title":"Allergic contact dermatitis to povidone-iodine","volume":"60","author":"Vel\u00e1zquez","year":"2009","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0205","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.0105-1873.2005.00499.x","article-title":"Allergic contact dermatitis from iodine preparations: a conundrum","volume":"52","author":"Lee","year":"2005","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000057734","article-title":"Patch testing to exclude allergic contact dermatitis caused by povidone-iodine","volume":"204","author":"Kozuka","year":"2002","journal-title":"Dermatol ogy"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2011.08.006_bb0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000057736","article-title":"Investigation of irritant skin reaction by 10% povidone-iodine solution after surgery","volume":"204","author":"Iijima","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2310\/6620.2008.07053","article-title":"Allergic contact dermatitis from medical adhesive bandages in patients who report having a reaction to medical bandages","volume":"19","author":"Widman","year":"2008","journal-title":"Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0536.2010.01718.x","article-title":"Contact dermatitis to self-adhesive ECG electrodes","volume":"62","author":"R\u00fchlemann","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0230","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0536.2010.01720.x","article-title":"Allergic contact dermatitis to Dermabond after orthopaedic joint replacement","volume":"62","author":"El-Dars","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2310\/6620.2009.08097","article-title":"Patch-test results of the North American Contact Dermatitis Group 2005-2006","volume":"20","author":"Zug","year":"2009","journal-title":"Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0240","first-page":"257","article-title":"Allergic contact dermatitis: patch testing results at Mount Sinai Medical Center","volume":"8","author":"Yoo","year":"2010","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0245","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0148607108319801","article-title":"The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants","volume":"32","author":"Paauw","year":"2008","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0250","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/7140.2006.00011","article-title":"Pyoderma gangrenosum versus chronic venous ulceration: comparison of diagnostic features","volume":"10","author":"Koo","year":"2006","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0255","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.rdc.2007.07.016","article-title":"Pyoderma gangrenosum: an update","volume":"33","author":"Callen","year":"2007","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0260","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","article-title":"Pyoderma gangrenosum: a review and update on new therapies","volume":"62","author":"Miller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jaad.2007.08.048","article-title":"Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings","volume":"58","author":"Fonder","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1468-3083.2007.02280.x","article-title":"Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%","volume":"22","author":"Bellini","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0275","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0280","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.sder.2006.08.006","article-title":"Off-label uses of biologic agents in dermatology: a 2006 update","volume":"25","author":"Kerns","year":"2006","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0536.2008.01351.x","article-title":"Hypersensitivity reactions associated with endovascular devices","volume":"59","author":"Honari","year":"2008","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0290","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2106\/00004623-200103000-00017","article-title":"Metal sensitivity in patients with orthopaedic implants","volume":"83","author":"Hallab","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0295","series-title":"Information for physicians on sub-acute thromboses (SAT) and hypersensitivity reactions with use of the Cordis CYPHER\u2122 coronary stent","author":"Alonge","year":"2003"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0300","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0190-9622(99)70126-X","article-title":"Anetoderma of prematurity in association with electrocardiographic electrodes","volume":"41","author":"Colditz","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0305","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archdermatol.2010.65","article-title":"Anetoderma of prematurity: an iatrogenic consequence of neonatal intensive care","volume":"146","author":"Goujon","year":"2010","journal-title":"Arch Dermatol"},{"issue":"suppl 2","key":"10.1016\/j.clindermatol.2011.08.006_bb0310","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0560.2006.00519.x","article-title":"Calcinosis cutis: a complication of intravenous administration of calcium gluconate","volume":"33","author":"Moss","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0315","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/bmjqs.2010.043125","article-title":"Assessing the adequacy of pressure ulcer prevention in hospitals: a nationwide prevalence survey","volume":"20","author":"Vanderwee","year":"2011","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0320","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00006199-198707000-00002","article-title":"The Braden Scale for predicting pressure sore risk","volume":"36","author":"Bergstrom","year":"1987","journal-title":"Nurs Res"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0325","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00006199-199809000-00005","article-title":"Reliability and validity of the Braden Scale: a multi-site study","volume":"47","author":"Bergstrom","year":"1998","journal-title":"Nurs Res"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0330","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1532-5415.1996.tb05633.x","article-title":"Multi-site study of incidence of pressure ulcers and the relationship between risk level, demographic characteristics, diagnoses, and prescription of preventive interventions","volume":"44","author":"Bergstrom","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0335","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/01.ASW.0000391184.43845.c1","article-title":"Pressure ulcer prevalence and incidence in acute care","volume":"23","author":"Jenkins","year":"2010","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0340","series-title":"Prevention and treatment of pressure ulcers: quick reference guide","author":"European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel","year":"2009"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0345","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1742-1241.1993.tb09663.x","article-title":"Potential for bed sores due to high pressures: influence of body sites, body position, and mattress design","volume":"47","author":"Allen","year":"1993","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0350","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1088\/0967-3334\/14\/3\/014","article-title":"Air-fluidized beds and their ability to distribute interface pressures generated between the subject and the bed surface","volume":"14","author":"Allen","year":"1993","journal-title":"Physiol Meas"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0355","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.296.8.974","article-title":"Preventing pressure ulcers: a systematic review","volume":"296","author":"Reddy","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijnurstu.2004.05.013","article-title":"The effect of various combinations of turning and pressure reducing devices on the incidence of pressure ulcers","volume":"42","author":"Defloor","year":"2005","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0365","first-page":"CD006898","article-title":"Repositioning for treating pressure ulcers","author":"Moore","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.12968\/jowc.2010.19.3.47282","article-title":"Local dressings for pressure ulcers: what is the best tool to apply in primary and second care?","volume":"19","author":"Lohi","year":"2010","journal-title":"J Wound Care"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0375","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/jama.2008.778","article-title":"Treatment of pressure ulcers: a systematic review","volume":"300","author":"Reddy","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2011.08.006_bb0380","first-page":"56","article-title":"Wet-to-dry gauze dressings: fact and fiction","volume":"16","author":"Armstrong","year":"2004","journal-title":"Wounds"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11002100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X11002100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T22:46:27Z","timestamp":1713048387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X11002100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0738081X11002100"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2011.08.006","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}